MARKET

ABT

ABT

Abbott
NYSE

Real-time Quotes | Nasdaq Last Sale

118.95
+0.16
+0.13%
After Hours: 118.95 0 0.00% 17:50 05/07 EDT
OPEN
119.77
PREV CLOSE
118.79
HIGH
120.42
LOW
118.76
VOLUME
4.08M
TURNOVER
--
52 WEEK HIGH
128.54
52 WEEK LOW
86.16
MARKET CAP
210.72B
P/E (TTM)
37.05
1D
5D
1M
3M
1Y
5Y
Mechanical Circulatory Support Devices Market with manufacturers, Application, regions and SWOT Analysis 2026
May 07, 2021 (Market Insight Reports) -- Selbyville, Delaware, Mechanical Circulatory Support Devices market report offer in-depth analysis and comprehensive...
Market Insight Reports · 2h ago
Seeking Alpha Catalyst Watch
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a
Seekingalpha · 3h ago
The Vanguard Health Care Fund Cuts Abbott Labs, Thermo Fisher
Firm's largest sales of the 1st quarter
GuruFocus.com · 5h ago
Electrochemical Biosensors Market 2021: Segmentation Analysis by Top Countries Data, Key Players, Market Size, Industry Share and Forecast by 2023
May 07, 2021 (AmericaNewsHour) -- Electrochemical biosensors are analytical devices used to provide analytical information by biological sample, such as...
AmericaNewsHour · 7h ago
Aquatic Herbicides Market Recent Research Report| BASF SE, The Dow Chemical Company and Monsanto Company
May 07, 2021 (WiredRelease via Comtex) -- MarketResearch.Biz one of the world’s prominent marketing research firm has launched a brand new report on Global...
marketresearch.biz · 8h ago
Irritable Bowel Syndrome Drugs Market Growth to Witness a Surge by Rise in Prevalence of the Disease with a Notable CAGR during 2020 - 2029
May 07, 2021 (AmericaNewsHour) -- Research Nester published a report titled "Irritable Bowel Syndrome Drugs Market: Global Demand Analysis & Opportunity...
AmericaNewsHour · 8h ago
Protein Hydrolysate Ingredients Market Research With Size, Growth, Key Players, Segments And Forecasts Analysis 2021-2027
May 07, 2021 (Heraldkeepers) -- Global Protein Hydrolysate Ingredients market report scope includes detailed study covering underlying factors influencing...
Heraldkeepers · 9h ago
Geriatric Medicines Market Analysis Report 2021 Prevailing Competition, Key Strategies Adopted, Recent Developments and Forecast to 2026
May 07, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" Global “Geriatric Medicines Market” has...
The Express Wire · 10h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ABT. Analyze the recent business situations of Abbott through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 23 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ABT stock price target is 135.84 with a high estimate of 158.00 and a low estimate of 111.00.
EPS
Institutional Holdings
Institutions: 2.97K
Institutional Holdings: 1.39B
% Owned: 78.41%
Shares Outstanding: 1.77B
TypeInstitutionsShares
Increased
923
37.84M
New
246
4.17M
Decreased
904
38.75M
Sold Out
59
3.49M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.43%
Healthcare Equipment & Supplies
+0.66%
Key Executives
Chairman/Executive Director
Miles White
President/Chief Executive Officer/Director
Robert Ford
Chief Financial Officer/Executive Vice President - Finance
Robert Funck
Executive Vice President/General Counsel/Secretary
Hubert Allen
Executive Vice President/Director of Human Resources
Mary Moreland
Executive Vice President
John Capek
Executive Vice President
Lisa Earnhardt
Executive Vice President
John Ginascol
Executive Vice President
Andrew Lane
Executive Vice President
Daniel Salvadori
Executive Vice President
Andrea Wainer
Senior Vice President
Gregory Ahlberg
Senior Vice President
Roger Bird
Senior Vice President
Charles Brynelsen
Senior Vice President
Michael Dale
Senior Vice President
Sammy Karam
Senior Vice President
Joseph Manning
Senior Vice President
Michael Pederson
Senior Vice President
Christopher Scoggins
Senior Vice President
Jared Watkin
Senior Vice President
Alejandro Wellisch
Senior Vice President
Randel Woodgrift
Vice President - Finance/Controller
Philip Boudreau
Lead Director/Independent Director
William Osborn
Independent Director
Robert Alpern
Independent Director
Roxanne Austin
Independent Director
Sally Blount
Independent Director
Michelle Kumbier
Independent Director
Darren McDew
Independent Director
Nancy McKinstry
Independent Director
Nancy Mckinstry
Independent Director
Daniel Starks
Independent Director
John Stratton
Independent Director
Glenn Tilton
Declaration Date
Dividend Per Share
Ex-Div Date
02/19/2021
Dividend USD 0.45
04/14/2021
12/11/2020
Dividend USD 0.45
01/14/2021
09/17/2020
Dividend USD 0.36
10/14/2020
06/12/2020
Dividend USD 0.36
07/14/2020
02/21/2020
Dividend USD 0.36
04/14/2020
12/13/2019
Dividend USD 0.36
01/14/2020
09/12/2019
Dividend USD 0.32
10/11/2019
06/14/2019
Dividend USD 0.32
07/12/2019
02/22/2019
Dividend USD 0.32
04/12/2019
12/14/2018
Dividend USD 0.32
01/14/2019
09/13/2018
Dividend USD 0.28
10/12/2018
06/08/2018
Dividend USD 0.28
07/12/2018
02/16/2018
Dividend USD 0.28
04/12/2018
12/15/2017
Dividend USD 0.28
01/11/2018
09/14/2017
Dividend USD 0.265
10/12/2017
06/09/2017
Dividend USD 0.265
07/12/2017
02/21/2017
Dividend USD 0.265
04/11/2017
12/12/2016
Dividend USD 0.265
01/11/2017
09/16/2016
Dividend USD 0.26
10/12/2016
06/10/2016
Dividend USD 0.26
07/13/2016
02/19/2016
Dividend USD 0.26
04/13/2016
12/11/2015
Dividend USD 0.26
01/13/2016
09/17/2015
Dividend USD 0.24
10/13/2015
06/12/2015
Dividend USD 0.24
07/13/2015
02/20/2015
Dividend USD 0.24
04/13/2015
02/11/2015
Dividend USD 0.24
01/13/2015
09/11/2014
Dividend USD 0.22
10/10/2014
06/13/2014
Dividend USD 0.22
07/11/2014
02/21/2014
Dividend USD 0.22
04/11/2014
10/16/2013
Dividend USD 0.22
01/13/2014
09/12/2013
Dividend USD 0.14
10/10/2013
06/14/2013
Dividend USD 0.14
07/11/2013
  • All
  • Financials
  • Insiders
More
About ABT
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products, including FreeStyle, PediaSure, Pedialyte, Similac, EleCare, ZonePerfect, Juven, Ensure and Glucerna. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. The cardiovascular's products include Portico, MitraClip, Dilatation Catheter, among others. The diagnostics products include IntelliFISH, Vysis ALK, STARLIMS, PathVysion, AlinIQ, among others.

Webull offers kinds of Abbott Laboratories stock information, including NYSE:ABT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABT stock methods without spending real money on the virtual paper trading platform.